Recent research suggests lecanemab may be less effective in females, raising important questions for future Alzheimer’s drug ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

Since becoming only the second Alzheimer's-modifying drug to gain American Federal Drug Administration approval in 2023, ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Meanwhile, two similar drugs — lecanemab, or Leqembi ... we have learned about the value of amyloid removal in sporadic AD, these data are encouraging,” Dr. Paul Aisen, director of the ...